NBIX NEUROCRINE BIOSCIENCES INC
Nasdaq · SEC CIK 914475 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $77.87M 26 sales by 15 insiders
- Filings on record
- 361 since 2021-07-29, latest 2026-09-15 17:07
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| GORMAN KEVIN CHARLES | Dir | — | $37.82M |
| Cooke Julie | CHRO | — | $5.77M |
| Gano Kyle | CEO, Dir | — | $4.87M |
| Lippoldt Darin | CLO | — | $4.20M |
| SHERWIN STEPHEN A | Dir | — | $4.13M |
| Delaet Ingrid | Chief Regulatory Off | — | $3.75M |
| Onyia Jude | CSO | — | $3.47M |
| RASTETTER WILLIAM H | Dir | — | $2.73M |
| POPS RICHARD F | Dir | — | $2.36M |
| LYONS GARY A | Dir | — | $2.29M |
Transactions 470
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-22 | 2024-02-20 | NBIX | POPS RICHARD F | Dir | S - Sale+OE | $132.47 | -15.0K | 29.5K | -34% | -$1.99M |
| D | 2024-02-22 | 2024-02-20 | NBIX | POPS RICHARD F | Dir | M - OptEx | $12.98 | +15.0K | 44.5K | +51% | +$194.7K |
| D | 2024-02-15 | 2024-02-13 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale | $133.01 | -1,098 | 40.6K | -3% | -$146.0K |
| D | 2024-02-15 | 2024-02-13 | NBIX | Lippoldt Darin | CLO | S - Sale | $132.99 | -1,098 | 39.7K | -3% | -$146.0K |
| D | 2024-02-15 | 2024-02-13 | NBIX | GORMAN KEVIN CHARLES | CEO, Dir | S - Sale | $133.02 | -2,832 | 514.6K | -0.5% | -$376.7K |
| D | 2024-02-15 | 2024-02-13 | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale | $132.96 | -1,114 | 23.7K | -4% | -$148.1K |
| D | 2024-02-15 | 2024-02-13 | NBIX | Gano Kyle | Chief Business Development Off | S - Sale | $132.89 | -1,352 | 135.2K | -1.0% | -$179.7K |
| D | 2024-02-15 | 2024-02-13 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale | $133.03 | -716 | 7,507 | -9% | -$95.2K |
| D | 2024-02-15 | 2024-02-13 | NBIX | Onyia Jude | CSO | S - Sale | $132.94 | -1,432 | 13.1K | -10% | -$190.4K |
| D | 2024-02-15 | 2024-02-13 | NBIX | Cooke Julie | CHRO | S - Sale | $133.04 | -796 | 18.0K | -4% | -$105.9K |
| D | 2024-02-15 | 2024-02-13 | NBIX | ABERNETHY MATT | CFO | S - Sale | $132.85 | -1,352 | 31.5K | -4% | -$179.6K |
| DM | 2024-02-15 | 2024-02-13 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $133.08 | -1,811 | 5,751 | -24% | -$241.0K |
| DM | 2024-02-14 | 2024-02-13 | NBIX | GORMAN KEVIN CHARLES | CEO, Dir | M - OptEx | $39.28 | +5,090 | 512.1K | +1% | +$200.0K |
| M | 2024-02-08 | 2024-02-06+ | NBIX | Cooke Julie | CHRO | S - Sale | $138.61 | -2,544 | 17.3K | -13% | -$352.6K |
| M | 2024-02-08 | 2024-02-06+ | NBIX | ABERNETHY MATT | CFO | S - Sale | $138.73 | -2,260 | 30.3K | -7% | -$313.5K |
| M | 2024-02-08 | 2024-02-06+ | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale | $138.68 | -2,260 | 39.6K | -5% | -$313.4K |
| M | 2024-02-08 | 2024-02-06+ | NBIX | Lippoldt Darin | CLO | S - Sale | $138.47 | -1,952 | 37.9K | -5% | -$270.3K |
| M | 2024-02-08 | 2024-02-06+ | NBIX | Gano Kyle | Chief Business Development Off | S - Sale | $139.16 | -2,580 | 134.0K | -2% | -$359.0K |
| M | 2024-02-08 | 2024-02-06+ | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $137.09 | -1,784 | 4,894 | -27% | -$244.6K |
| M | 2024-02-08 | 2024-02-06+ | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale | $138.49 | -2,101 | 22.7K | -8% | -$291.0K |
| M | 2024-02-08 | 2024-02-06+ | NBIX | GORMAN KEVIN CHARLES | CEO, Dir | S - Sale | $138.74 | -5,314 | 507.0K | -1% | -$737.3K |
| 2024-02-02 | 2024-01-31 | NBIX | GORMAN KEVIN CHARLES | CEO, Dir | S - Sale | $140.69 | -2,707 | 502.2K | -0.5% | -$380.8K | |
| 2024-02-02 | 2024-01-31 | NBIX | Lippoldt Darin | CLO | S - Sale | $140.65 | -1,250 | 37.0K | -3% | -$175.8K | |
| 2024-02-02 | 2024-01-31 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale | $140.78 | -1,207 | 37.6K | -3% | -$169.9K | |
| 2024-02-02 | 2024-01-31 | NBIX | ABERNETHY MATT | CFO | S - Sale | $140.72 | -1,283 | 28.3K | -4% | -$180.5K | |
| 2024-02-02 | 2024-01-31 | NBIX | Onyia Jude | CSO | S - Sale | $141.94 | -126 | 11.8K | -1% | -$17.9K | |
| M | 2024-02-02 | 2024-01-31+ | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale | $140.65 | -1,045 | 6,865 | -13% | -$147.0K |
| M | 2024-02-02 | 2024-01-31 | NBIX | Cooke Julie | CHRO | S - Sale | $141.29 | -1,740 | 18.1K | -9% | -$245.8K |
| 2024-02-02 | 2024-01-31 | NBIX | Gano Kyle | Chief Business Development Off | S - Sale | $140.70 | -1,541 | 131.6K | -1% | -$216.8K | |
| 2024-02-02 | 2024-01-31 | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale | $140.79 | -1,457 | 20.8K | -7% | -$205.1K | |
| M | 2024-02-02 | 2024-01-31 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $140.80 | -2,096 | 4,894 | -30% | -$295.1K |
| D | 2024-01-24 | 2024-01-22 | NBIX | Lippoldt Darin | CLO | S - Sale+OE | $139.86 | -10.0K | 35.9K | -22% | -$1.40M |
| D | 2024-01-24 | 2024-01-22 | NBIX | Lippoldt Darin | CLO | M - OptEx | $79.02 | +10.0K | 45.9K | +28% | +$790.2K |
| DM | 2024-01-10 | 2024-01-08+ | NBIX | GORMAN KEVIN CHARLES | CEO, Dir | M - OptEx | $19.59 | +167.9K | 561.8K | +43% | +$3.29M |
| DM | 2024-01-10 | 2024-01-08+ | NBIX | GORMAN KEVIN CHARLES | CEO, Dir | S - Sale+OE | $133.02 | -167.9K | 499.8K | -25% | -$22.33M |
| DM | 2024-01-04 | 2024-01-02 | NBIX | Gano Kyle | Chief Business Development Off | S - Sale+OE | $131.47 | -75.0K | 130.2K | -37% | -$9.86M |
| DM | 2024-01-04 | 2024-01-02 | NBIX | Gano Kyle | Chief Business Development Off | M - OptEx | $19.59 | +75.0K | 199.1K | +60% | +$1.47M |
| D | 2024-01-04 | 2024-01-02 | NBIX | RASTETTER WILLIAM H | Dir | M - OptEx | $12.98 | +20.0K | 62.8K | +47% | +$259.6K |
| D | 2024-01-04 | 2024-01-02 | NBIX | RASTETTER WILLIAM H | Dir | S - Sale+OE | $131.47 | -11.0K | 51.7K | -18% | -$1.45M |
| 2023-12-27 | 2023-12-22 | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale | $126.74 | -10.0K | 19.5K | -34% | -$1.27M | |
| DM | 2023-12-27 | 2023-12-22 | NBIX | Cooke Julie | CHRO | M - OptEx | $73.04 | +24.0K | 31.3K | +330% | +$1.75M |
| DM | 2023-12-27 | 2023-12-22 | NBIX | Cooke Julie | CHRO | S - Sale+OE | $128.66 | -24.0K | 17.3K | -58% | -$3.09M |
| 2023-12-27 | 2023-12-22 | NBIX | LYONS GARY A | Dir | S - Sale | $130.04 | -10.0K | 193.7K | -5% | -$1.30M | |
| DM | 2023-12-14 | 2023-12-12 | NBIX | ROBERTS EIRY | Chief Medical Off | M - OptEx | $81.05 | +13.9K | 36.5K | +62% | +$1.13M |
| DM | 2023-12-14 | 2023-12-12 | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale+OE | $120.30 | -13.9K | 29.5K | -32% | -$1.68M |
| DM | 2023-12-11 | 2023-12-07+ | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale+OE | $120.37 | -77.7K | 29.5K | -72% | -$9.35M |
| DM | 2023-12-11 | 2023-12-07+ | NBIX | ROBERTS EIRY | Chief Medical Off | M - OptEx | $78.53 | +77.7K | 68.2K | New | +$6.10M |
| D | 2023-12-08 | 2023-12-06 | NBIX | Lippoldt Darin | CLO | M - OptEx | $43.24 | +20.8K | 56.7K | +58% | +$900.7K |
| D | 2023-12-08 | 2023-12-06 | NBIX | Lippoldt Darin | CLO | S - Sale+OE | $119.86 | -20.8K | 35.9K | -37% | -$2.50M |
| D | 2023-12-08 | 2023-12-06 | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale+OE | $120.03 | -8,396 | 29.5K | -22% | -$1.01M |
| D | 2023-12-08 | 2023-12-06 | NBIX | ROBERTS EIRY | Chief Medical Off | M - OptEx | $77.81 | +8,396 | 37.9K | +28% | +$653.3K |
| D | 2023-12-05 | 2023-12-01 | NBIX | LYONS GARY A | Dir | M - OptEx | $12.98 | +5,000 | 208.7K | +2% | +$64.9K |
| D | 2023-12-05 | 2023-12-01 | NBIX | LYONS GARY A | Dir | S - Sale+OE | $116.77 | -5,000 | 203.7K | -2% | -$583.9K |
| 2023-12-01 | 2023-11-29 | NBIX | Onyia Jude | CSO | S - Sale | $113.57 | -2,331 | 11.7K | -17% | -$264.7K | |
| 2023-11-29 | 2023-11-27 | NBIX | Lippoldt Darin | CLO | S - Sale | $112.27 | -10.9K | 35.9K | -23% | -$1.23M | |
| 2023-11-20 | 2023-11-16 | NBIX | SHERWIN STEPHEN A | Dir | G - Gift | $0.00 | -2,750 | 22.3K | -11% | $0 | |
| 2023-10-04 | 2023-10-02 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $112.68 | -1,437 | 4,894 | -23% | -$161.9K | |
| D | 2023-09-14 | 2023-09-12 | NBIX | LYONS GARY A | Dir | S - Sale+OE | $115.02 | -5,000 | 203.7K | -2% | -$575.1K |
| D | 2023-09-14 | 2023-09-12 | NBIX | LYONS GARY A | Dir | M - OptEx | $12.98 | +5,000 | 208.7K | +2% | +$64.9K |
| 2023-09-06 | 2023-09-01 | NBIX | Cooke Julie | CHRO | S - Sale | $110.93 | -824 | 17.3K | -5% | -$91.4K | |
| D | 2023-09-06 | 2023-09-01 | NBIX | LYONS GARY A | Dir | S - Sale+OE | $110.06 | -5,000 | 203.7K | -2% | -$550.3K |
| D | 2023-09-06 | 2023-09-01 | NBIX | LYONS GARY A | Dir | M - OptEx | $12.98 | +5,000 | 208.7K | +2% | +$64.9K |
| M | 2023-09-01 | 2023-08-30 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $107.59 | -2,733 | 3,460 | -44% | -$294.1K |
| 2023-09-01 | 2023-08-30 | NBIX | Lippoldt Darin | CLO | G - Gift | $0.00 | -190 | 46.8K | -0.4% | $0 | |
| 2023-08-30 | 2023-08-28 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale | $107.52 | -1,431 | 5,931 | -19% | -$153.9K | |
| 2023-08-23 | 2023-08-21 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $107.41 | -1,600 | 6,193 | -21% | -$171.9K | |
| 2023-08-23 | 2023-08-21 | NBIX | Gano Kyle | Chief Business Development Off | S - Sale | $107.41 | -2,132 | 130.2K | -2% | -$229.0K | |
| 2023-08-23 | 2023-08-21 | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale | $107.38 | -3,198 | 29.5K | -10% | -$343.4K | |
| 2023-08-23 | 2023-08-21 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale | $107.42 | -1,404 | 4,645 | -23% | -$150.8K | |
| 2023-08-23 | 2023-08-21 | NBIX | GORMAN KEVIN CHARLES | CEO, Dir | S - Sale | $107.40 | -9,328 | 499.8K | -2% | -$1.00M | |
| 2023-08-23 | 2023-08-21 | NBIX | ABERNETHY MATT | CFO | S - Sale | $107.39 | -2,132 | 27.1K | -7% | -$229.0K | |
| 2023-08-23 | 2023-08-21 | NBIX | Onyia Jude | CSO | S - Sale | $107.37 | -3,198 | 9,638 | -25% | -$343.4K | |
| 2023-08-23 | 2023-08-21 | NBIX | Cooke Julie | CHRO | S - Sale | $107.41 | -2,132 | 18.1K | -11% | -$229.0K | |
| 2023-08-23 | 2023-08-21 | NBIX | Lippoldt Darin | CLO | S - Sale | $107.39 | -2,132 | 47.0K | -4% | -$229.0K | |
| 2023-08-23 | 2023-08-21 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale | $107.40 | -1,600 | 36.4K | -4% | -$171.8K | |
| 2023-05-03 | 2023-05-01 | NBIX | Cooke Julie | CHRO | S - Sale | $103.89 | -11.4K | 16.2K | -41% | -$1.18M | |
| D | 2023-05-03 | 2023-05-01 | NBIX | RASTETTER WILLIAM H | Dir | S - Sale+OE | $101.43 | -4,300 | 42.8K | -9% | -$436.1K |
| D | 2023-05-03 | 2023-05-01 | NBIX | RASTETTER WILLIAM H | Dir | M - OptEx | $12.71 | +7,625 | 47.1K | +19% | +$96.9K |
| 2023-04-27 | 2023-04-25 | NBIX | Cooke Julie | CHRO | S - Sale | $103.82 | -100 | 27.6K | -0.4% | -$10.4K | |
| 2023-04-26 | 2023-04-24 | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale | $103.48 | -14.4K | 26.6K | -35% | -$1.49M | |
| DM | 2023-04-21 | 2023-04-19+ | NBIX | RASTETTER WILLIAM H | Dir | M - OptEx | $12.71 | +12.4K | 35.6K | +53% | +$157.3K |
| DM | 2023-04-21 | 2023-04-19+ | NBIX | RASTETTER WILLIAM H | Dir | S - Sale+OE | $105.03 | -6,937 | 34.7K | -17% | -$728.6K |
| 2023-02-08 | 2023-02-07 | NBIX | Onyia Jude | CSO | S - Sale | $102.30 | -4,508 | 6,525 | -41% | -$461.2K | |
| M | 2023-02-08 | 2023-02-06+ | NBIX | ABERNETHY MATT | CFO | S - Sale | $102.61 | -28.6K | 35.8K | -44% | -$2.93M |
| M | 2023-02-08 | 2023-02-06+ | NBIX | Cooke Julie | CHRO | S - Sale | $102.77 | -17.1K | 15.9K | -52% | -$1.76M |
| M | 2023-02-08 | 2023-02-06+ | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $102.49 | -25.2K | 4,755 | -84% | -$2.59M |
| M | 2023-02-08 | 2023-02-06+ | NBIX | GORMAN KEVIN CHARLES | CEO, Dir | S - Sale | $102.90 | -29.0K | 470.9K | -6% | -$2.99M |
| M | 2023-02-08 | 2023-02-06+ | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale | $102.74 | -16.5K | 40.1K | -29% | -$1.70M |
| M | 2023-02-08 | 2023-02-06+ | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale | $102.70 | -19.6K | 33.5K | -37% | -$2.02M |
| M | 2023-02-08 | 2023-02-06+ | NBIX | Gano Kyle | Chief Business Development Off | S - Sale | $102.79 | -17.0K | 115.7K | -13% | -$1.75M |
| M | 2023-02-08 | 2023-02-06+ | NBIX | Lippoldt Darin | CLO | S - Sale | $102.71 | -16.3K | 32.7K | -33% | -$1.67M |
| M | 2023-02-08 | 2023-02-06+ | NBIX | Lloyd-Smith Malcolm | Chief Integration Off | S - Sale | $102.64 | -15.3K | 30.2K | -34% | -$1.57M |
| 2023-02-02 | 2023-01-31 | NBIX | ABERNETHY MATT | CFO | S - Sale | $109.98 | -1,283 | 21.4K | -6% | -$141.1K | |
| 2023-02-02 | 2023-01-31 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale | $109.95 | -1,207 | 16.7K | -7% | -$132.7K | |
| 2023-02-02 | 2023-01-31 | NBIX | Gano Kyle | Chief Business Development Off | S - Sale | $109.98 | -1,541 | 112.8K | -1% | -$169.5K | |
| 2023-02-02 | 2023-01-31 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $109.92 | -1,104 | 3,911 | -22% | -$121.4K | |
| 2023-02-02 | 2023-01-31 | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale | $109.99 | -1,457 | 26.2K | -5% | -$160.3K | |
| 2023-02-02 | 2023-01-31 | NBIX | GORMAN KEVIN CHARLES | CEO, Dir | S - Sale | $110.08 | -2,707 | 465.3K | -0.6% | -$298.0K | |
| 2023-02-02 | 2023-01-31 | NBIX | Lippoldt Darin | CLO | S - Sale | $109.97 | -1,250 | 30.4K | -4% | -$137.5K | |
| 2023-02-02 | 2023-01-31 | NBIX | Lloyd-Smith Malcolm | Chief Integration Off | S - Sale | $110.02 | -1,666 | 28.6K | -6% | -$183.3K |
Purchase Sale Sale after option exercise All abbreviations